Membrane Transport in Heart Failure

This feed focuses on Membrane Transport proteins and their dysfunction which can lead to heart disease. Discover the latest research on Membrane Transport in Heart Failure.

January 16, 2022

Poncirin ameliorates cardiac ischemia-reperfusion injury by activating PI3K/AKT/PGC-1α signaling.

European Journal of Pharmacology
Bingda LiPing Li
January 16, 2022

DEHP-induced mitophagy and mitochondrial damage in the heart are associated with dysregulated mitochondrial biogenesis.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Hao ZhangJin-Long Li
January 16, 2022

FNDC5/irisin reduces ferroptosis and improves mitochondrial dysfunction in hypoxic cardiomyocytes by Nrf2/HO-1 Axis.

Cell Biology International
Guang-Ying CaoTao-Hong Hu
January 16, 2022

Sirtuin 3: Emerging therapeutic target for cardiovascular diseases.

Free Radical Biology & Medicine
Mengfei CaoWei Yuan
January 15, 2022

Molecular mechanisms of cognitive impairment associated with stroke.

Metabolic Brain Disease
Mandeep Kaur, Saurabh Sharma
January 15, 2022

Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations.

American Journal of Physiology. Heart and Circulatory Physiology
Alexandra RhodenThomas Eschenhagen
January 14, 2022

Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: A comprehensive review.

Ram B SinghGalal E Nagib Elkilany
January 14, 2022

Copper modulates heart mitochondrial H2O2 emission differently during fatty acid and pyruvate oxidation.

Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
Michael O IseiCollins Kamunde
January 14, 2022

Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease.

Human Molecular Genetics
Florian A SchoberAnna Wredenberg
January 14, 2022

Calorie restriction changes lipidomic profiles and maintains mitochondrial function and redox balance during isoproterenol-induced cardiac hypertrophy.

Journal of Physiology and Biochemistry
Cícera Edna Barbosa DavidHeberty Tarso Facundo
January 13, 2022

Nivalenol affects spindle formation and organelle functions during mouse oocyte maturation.

Toxicology and Applied Pharmacology
Yue WangShao-Chen Sun
January 13, 2022

Early-onset dietary restriction maintains mitochondrial health, autophagy and ER function in the left ventricle during aging.

The Journal of Nutritional Biochemistry
Sin-Jin LiChing-Yi Chen
January 13, 2022

Sudden cardiac death in diabetes and obesity: mechanisms and therapeutic strategies.

The Canadian Journal of Cardiology
Carol Ann Remme
January 13, 2022

Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment.

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Maria Rosaria RizzoGiuseppe Paolisso
January 13, 2022

Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart.

Cardiovascular Research
Jihoon NahJunichi Sadoshima
January 12, 2022
Open Access

Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

International Journal of Molecular Sciences
Jérôme PiquereauMathias Mericskay

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2022 Meta ULC. All rights reserved